HIV 1 transcription: Tat/novel cofactors/Mechanisms
HIV 1 transcription: Tat/novel cofactors/Mechanisms
批准号:
7102120
负责人:
CAMILO A PARADA
金额:
$2.06万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-01 至 2008-01-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The HIV-l-encoded Tat protein is a potent transcriptional activator that is essential for viral replication. The long-term objective of this proposal is to gain a better understanding of the control of HIV-1 gene expression by Tat and cellular factors at the molecular level. This study will focus on a novel RNA Pol II complex (Tat- SF) that mediates Tat-enhanced transcription (Tat function). Tat-SF contains several factors (e.g., Spt5/Spt4, P-TEFb) and novel polypeptides, but none of the SRB/MED proteins. These Tat-SF cofactors are jointly required for general transcription and Tat function. This proposal has four specific aims. The first is to identify novel components of Tat-SF and examine their mechanisms of action. The polypeptide composition of the Tat-SF cofactors will be characterized by chromatographic methods and biochemical complementation assays. After the novel Tat-SF cofactors are identified by mass spectrometry and cloned, their interplay with other Tat-SF cofactors for Tat activity will be studied. The second will employ mutagenesis to determine the structure-function relationships of novel Tat-SF cofactors among themselves and with other transcription factors necessary for Tat function. The third will address the interplay of the Tat- SF cofactors and the SRB/MED complex for Tat activity. These experiments will include the detailed characterization of a potential SRB/MED complex-containing scaffold formed on the HIV-1 promoter that could be utilized by Tat-SF for transcription reinitiation. The effects of Tat and Tat-SF cofactors on Tat-SFand RNA Pol II holoenzyme-mediated reinitiation will be studied. Finally, the fourth aim will study the role of Tat in HIV-1 transcription on chromatin. A reconstituted system for Tat-dependent transcription on naked DNA will be optimized for Tat function on chromatin. The effects on chromatin of known factors necessary for transcription will be examined first, before further screening for potential activities that could complement the system for Tat function. Other studies will determine the effects of Tat, Tat-SF cofactors, and SRB/MED complex on transcription reinitiation on chromatin. These studies will establish a unique system for future elaboration of the link between HIV-1 transcription elongation and mRNA processing. Together, understanding Tat-enhanced HIV-1 transcription at the molecular level will be instrumental for future therapeutic antiviral strategies to block viral replication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HIV 1 transcription: Tat/novel cofactors/Mechanisms
-
批准号:6892475
-
项目类别:
-
资助金额:$21.77万
-
财政年份:2005
-
负责人:CAMILO A PARADA
-
依托单位:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
-
批准号:7008196
-
项目类别:
-
资助金额:$26.29万
-
财政年份:2005
-
负责人:CAMILO A PARADA
-
依托单位:
HIV 1 transcription: Tat/novel cofactors/Mechanisms
-
批准号:7174181
-
项目类别:
-
资助金额:$25.76万
-
财政年份:2005
-
负责人:CAMILO A PARADA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
-
批准号:82371145
-
项目类别:面上项目
-
资助金额:46.00万元
-
批准年份:2023
-
负责人:陶永
-
依托单位:
转录因子BCL6抑制ICOSL表达优化生发中心反应的机制研究
-
批准号:82371745
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:张文倩
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
小鼠肺腺鳞癌转分化类器官模型的建立及表观调控分子机制研究
-
批准号:32100593
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:童欣媛
-
依托单位:
NFATc3转录调控MMP14介导少突胶质细胞瘤血管新生促肿瘤恶变的机制研究
-
批准号:32100563
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:齐琳
-
依托单位:
KLF5诱导小鼠始发态多能性干细胞向滋养层干细胞转变的作用与机制研究
-
批准号:32100596
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:黄颖华
-
依托单位:
锌指蛋白ZBTB17调控成纤维细胞衰老的机制研究
-
批准号:32000509
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:马兴杰
-
依托单位:
细胞衰老抑制直接重编程及心肌再生修复的分子机理研究
-
批准号:92068107
-
项目类别:重大研究计划
-
资助金额:79.0万元
-
批准年份:2020
-
负责人:王丽
-
依托单位:
转录因子SALL4通过影响pre-mRNA可变剪接调控非Yamanaka因子体细胞重编程的机制研究
-
批准号:32000502
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王波
-
依托单位:
DNA糖苷酶OGG1调节PARP1介导的EB病毒潜伏蛋白表达的机制研究
-
批准号:32000546
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:郝文静
-
依托单位: